SQI Diagnostics signs commercial contract with global biotech

By Melissa Fassbender contact

- Last updated on GMT

SQI develops custom research and diagnostic assays. (Image: iStock/JK1991)
SQI develops custom research and diagnostic assays. (Image: iStock/JK1991)

Related tags: Contract, Biotechnology

SQI Diagnostics Inc. has signed an agreement to commercialize a custom multiplexed assay for a Waltham, MA-based global biotechnology company's blood disorder drug program.

As part of the agreement, SQI will provide sample analysis and data reporting services on human study samples using a custom-developed test unique to the unnamed customers biologic therapeutic.

Russell Peloquin, vice president, Global Commercial Operations at SQI Diagnostics told us the custom assay provider is excited to begin the commercial relationship with the company, with which they have not worked before.

Contracts have been signed and a purchase order has been received​,” he said. “We are now awaiting reagents from the customer that are scheduled to arrive shortly​.”

Once the reagents are received, the company will complete its assay development processes and will begin receiving samples for analysis and reporting to the customer.

As a small company, Peloquin said it is constantly going head-to-head with incumbent platforms that have been around for years.

As part of target customers’ vetting process, we are being measured against these older technologies​,” he explained. However, as he said is demonstrated with the most recent commercial contract, Peloquin added, “the industry has gained enough confidence in not only our technology, but also in our unique and flexible business models to afford us credibility throughout the market​.”

Related news

Related products

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

CellCarta | 17-Jan-2022 | Product Presentation

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us


View more